Patent · US Expired

Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide

US6844360B2 · kind B2 · utility

11Cited by

3References

11Claims

0Family size

Assignee

Boehringer Ingelheim Pharmaceuticals, Inc. · US

Inventors

Terence A. Kelly · Ridgefield, US
Jin Mi Kim · Sandy Hook, US
Rene Lemieux · Boston, US

Key dates

Filing date	Oct 15, 2003
Grant date	Jan 18, 2005
Priority date	—
Expiry date	Oct 15, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.